Utah Medical Products, Inc.

NasdaqGS UTMD

Utah Medical Products, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2024: USD 12.29

Utah Medical Products, Inc. Revenue Per Share is USD 12.29 for the Trailing 12 Months (TTM) ending September 30, 2024, a 2.21% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Utah Medical Products, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 12.02, a -15.11% change year over year.
  • Utah Medical Products, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 14.16, a 7.22% change year over year.
  • Utah Medical Products, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 13.21, a 15.73% change year over year.
  • Utah Medical Products, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 11.41, a -5.26% change year over year.
Key data
Date Revenue Per Share Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA)
Market news
Loading...
NasdaqGS: UTMD

Utah Medical Products, Inc.

CEO Mr. Kevin L. Cornwell
IPO Date March 8, 1999
Location United States
Headquarters 7043 South 300 West
Employees 169
Sector Health Care
Industries
Description

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

Similar companies

ATR

AptarGroup, Inc.

USD 154.61

0.47%

PDEX

Pro-Dex, Inc.

USD 45.00

-3.72%

ATRC

AtriCure, Inc.

USD 34.69

0.87%

MMSI

Merit Medical Systems, Inc.

USD 99.89

4.44%

KRMD

KORU Medical Systems, Inc.

USD 4.07

3.04%

ICUI

ICU Medical, Inc.

USD 161.08

1.85%

LMAT

LeMaitre Vascular, Inc.

USD 95.85

1.78%

ANGO

AngioDynamics, Inc.

USD 11.80

-5.30%

POCI

Precision Optics Corporation, Inc.

USD 4.76

-2.46%

AKYA

Akoya Biosciences, Inc.

USD 2.60

-11.26%

INFU

InfuSystem Holdings, Inc.

USD 7.87

-0.51%

StockViz Staff

January 15, 2025

Any question? Send us an email